Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.00 (1.83%)
Bid:
432.00
Ask:
444.00
Spread: 12.00 (2.778%)
Market Cap: £219.71m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

PRE-CLOSE TRADING UPDATE

25 Jul 2024 07:00

RNS Number : 7154X
City of London Investment Group PLC
25 July 2024
 

City of London Investment Group PLC

25 July 2024

 

The information contained within this announcement is deemed by the Group to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.



CITY OF LONDON INVESTMENT GROUP PLC

("City of London" or "the Group" or "the Company" or "CLIG")

PRE-CLOSE TRADING UPDATE for the year to 30 June 2024

 

City of London (LSE: CLIG), a leading specialist asset management group offering a range of institutional and retail products investing primarily in closed-end funds ("CEFs"), provides a pre-close trading update for its financial year ended 30 June 2024. The numbers that follow are unaudited.

 

Funds under Management (FuM) were $10.2 billion at 30 June 2024, an increase of 8.7% as compared to $9.4 billion at 30 June 2023. A breakdown by strategy follows:

 

FuM ($ million)

Jun-23

Actual

Net flows

Market & investment performance

Jun-24

(estimate)

 

EM

3,580

(424)

413

3,568

KIM

3,520

(4)

408

3,924

INTL

1,983

153

257

2,394

OV

244

(33)

40

251

Other*

97

(12)

19

104

9,424

(320)

1,137

10,241

* includes Frontier and seed investments

Funds under Management figures are rounded

 

IM Performance

 

Investment performance was ahead of the benchmark for the majority of the Group's strategies during the financial year. CLIM's International Equity, Opportunistic Value and Frontier Markets outperformed, while Emerging Markets (EM) equity lagged its index over the period. KIM's fixed income strategies, international equity, conservative balanced and SPAC strategies outperformed their market indices over the period, while the US equity strategy lagged its benchmark.

 

Flows

 

Net investment outflows reduced significantly to $26 million in the second half of the financial year, from $294 million in the first six months ending December 2023. Net investment outflows totaled $320 million for the Group over the twelve-month financial year as clients reduced exposure to EM due to ongoing geopolitical volatility. International equity strategies attracted more than $150 million in net new inflows over the period. Attractive discounts in the strategies continue to be the focus of marketing efforts across the Group's asset classes.

 

Dividend

 

The Board expects the final dividend for the year ended 30 June 2024 to be in line with the previous year.

Following the completion of the year-end audit, the Board will announce the final dividend and results alongside publication of its Accounts for the year ended 30 June 2024 on 17 September 2024.

 

The Group's Annual General Meeting will be held on 28 October 2024 and the Group expects the dividend payment date to be in November 2024 similar to last year's timing.

 

 

 

For further information, please visit https://www.clig.com/ or contact:

 

Tom Griffith, CEO

City of London Investment Group PLC

Tel: 001-610-380-0435

 

Martin Green / James Hornigold

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20-3829-5000

 

This release includes forward-looking statements, which may differ from actual results. Any forward-looking statements are based on certain factors and assumptions, which may prove incorrect, and are subject to risks, uncertainties and assumptions relating to future events, the Group's operations, results of operations, growth strategy and liquidity.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEEFILELSELW
Date   Source Headline
23rd May 20244:32 pmRNSDirector Declaration
7th May 202410:27 amEQSQ&A on City of London Investment Group (CLIG): Funds under management boosted by positive inflows
1st May 202411:58 amEQSHardman & Co Research on City of London Investment Group (CLIG): Positive inflows boost FUM
22nd Apr 20247:00 amRNSTrading Update
22nd Mar 20244:13 pmRNSHolding(s) in Company
21st Mar 20245:46 pmRNSHolding(s) in Company
20th Mar 20245:59 pmRNSHolding(s) in Company
14th Mar 202411:49 amRNSINTERIM DIVIDEND – US DOLLAR CONVERSION RATE
8th Mar 20241:24 pmRNSChange of Auditor
7th Mar 20245:15 pmRNSDirector/PDMR Shareholding
7th Mar 202412:05 pmEQSHardman & Co Research on NB Private Equity Partners (NBPE): Value creation in a higher-rate environment
6th Mar 202410:50 amEQSHardman & Co Research on City of London Investment Group (CLIG): First-half results going in the right direction
23rd Feb 20247:00 amRNSHALF YEAR RESULTS AND BOARD CHANGES
31st Jan 202410:50 amEQSHardman & Co Research on City of London Investment Group (CLIG): Bounce back in FUM after strong quarter
22nd Jan 20247:00 amRNSSIX MONTH TRADING UPDATE AND DIVIDEND DECLARATION
14th Dec 20233:12 pmRNSDirector/PDMR Shareholding
14th Dec 20232:58 pmRNSDirector/PDMR Shareholding
1st Nov 20235:30 pmRNSHolding(s) in Company
27th Oct 20235:10 pmRNSDirector/PDMR Shareholding
27th Oct 20235:08 pmRNSDirector/PDMR Shareholding
27th Oct 20235:07 pmRNSDirector/PDMR Shareholding
27th Oct 20235:07 pmRNSDirector/PDMR Shareholding
27th Oct 20235:05 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:47 pmRNSResult of AGM and Board Committee changes
17th Oct 20231:08 pmRNSHolding(s) in Company
17th Oct 202312:40 pmEQSHardman & Co Research on City of London Investment Group (CLIG): Weak markets weigh on FUM
13th Oct 20238:12 amRNSFunds Under Management - 30/09/23 - Trading Update
12th Oct 20235:10 pmEQSHardman & Co Analyst Interview on City of London Investment Group (CLIG): Performance pays dividends
12th Oct 20235:01 pmRNSHolding(s) in Company
3rd Oct 20233:40 pmEQSHardman & Co Research: City of London Investment Group (CLIG) - Performance pays dividends
3rd Oct 20237:00 amRNSBOARD AND MANAGEMENT UPDATE
18th Sep 20237:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2023
3rd Aug 20236:10 pmRNSTCFD Report
1st Aug 202310:00 amEQSHardman & Co Research on City of London Investment Group (CLIG): Positive markets offset by revenue margins
25th Jul 20237:00 amRNSPRE-CLOSE TRADING UPDATE for year to 30 June 2023
9th Jun 20233:50 pmRNSHolding(s) in Company
6th Jun 20236:15 pmRNSHolding(s) in Company
5th Jun 20237:00 amRNSHolding(s) in Company
26th May 20233:54 pmRNSBOARD CHANGES
23rd May 20233:34 pmRNSHolding(s) in Company
15th May 20239:58 amRNSHolding(s) in Company
12th May 20237:00 amRNSHolding(s) in Company
11th May 202312:05 pmRNSHolding(s) in Company
28th Apr 202310:05 amEQSHardman & Co Research | City of London Investment Group (CLIG): Positive markets offset by revenue margins
28th Apr 20237:00 amRNSHolding(s) in Company
26th Apr 20238:13 amRNSHolding(s) in Company
25th Apr 20237:00 amRNSTrading update
14th Apr 20231:15 pmEQSHardman & Co Q&A on City of London Investment Group (CLIG): Continuing its good performance
4th Apr 20235:10 pmRNSHolding(s) in Company
31st Mar 20239:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.